Ophthalmic manifestations of demyelination secondary to etanercept

Clin Exp Ophthalmol. 2008 May;36(4):392-4. doi: 10.1111/j.1442-9071.2008.001741.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy
  • Demyelinating Diseases / chemically induced*
  • Demyelinating Diseases / complications*
  • Etanercept
  • Eye Diseases / etiology*
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Middle Aged
  • Receptors, Tumor Necrosis Factor

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept